Sands Capital Alternatives, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 13, 2024), Sands Capital Alternatives, LLC reported 20 stock positions worth $298.6 million. Its top holding was Nu Holdings Ltd./Cayman Isl-A (NU) at 31.6% of the portfolio, followed by Klaviyo Class A (KVYO, 29.3%) and DoorDash Class A (DASH, 15.4%). Compared with Q1 2024, it added to 3 and reduced 7. The biggest buy was Klaviyo Class A (KVYO, shares +0%) and the biggest sale Uipath Class A (PATH, shares −50%).

Most Recent 13F
Q2 2026
Location
ARLINGTON, VA
CIK
0001846444
Portfolio Value
$298.6M (Q2 2024)
SEC Filing
0001020066-24-000007 ↗ filed Aug 13, 2024

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $414.7M Q1 2024 Q2 2024: $298.6M $298.6M Q2 2024 Q3 2024: $355.8M Q3 2024 Q4 2024: $459.7M Q4 2024 Q1 2025: $408.9M Q1 2025 Q2 2025: $507.8M Q2 2025 Q3 2025: $456.4M Q3 2025 Q4 2025: $518.5M Q4 2025 Q1 2026: $421.2M Q1 2026 Q2 2026: $613.5M Q2 2026

Holdings 20 stocks · $298.6M

NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD 31.64% 7,328,294 $94.5M Reduce -20.0%
KVYO Klaviyo Inc. Class A 29.31% 3,516,221 $87.5M Add +0.0%
DASH DoorDash Inc. Class A 15.41% 423,091 $46.0M Reduce -19.1%
PATH Uipath Inc. Class A 4.91% 1,155,246 $14.6M Reduce -49.9%
SNOW Snowflake Inc. 4.90% 108,304 $14.6M Reduce -49.8%
ACRV Acrivon Therapeutics Inc. 4.12% 2,122,605 $12.3M Add +28.4%
TXG 10X Genomics Inc. Class A 3.14% 481,770 $9.4M No change
ABOS Acumen Pharmaceuticals Inc. 2.77% 3,417,075 $8.3M No change
TARS Tarsus Pharmaceuticals Inc. 1.55% 170,000 $4.6M No change
CADL Candel Therapeutics Inc. 0.84% 405,837 $2.5M Reduce -50.0%
TSHA Taysha Gene Therapies Inc. 0.54% 724,873 $1.6M No change
MASS 908 Devices Inc. 0.41% 237,258 $1.2M No change
SPRB Spruce Biosciences Inc. 0.14% 787,007 $409K No change
CPNG Coupang Inc. 0.08% 11,931 $250K No change
ABSI Absci Corp. 0.06% 57,804 $178K No change
IOT Samsara Inc. Class A 0.05% 4,239 $143K Add +18.7%
DDOG Datadog Inc. Class A 0.04% 1,015 $132K No change
TOST Toast Inc. Class A 0.04% 4,945 $127K Reduce -16.9%
CRWD CrowdStrike Holdings Inc. Class A 0.03% 221 $85K Reduce -20.8%
GTLB Gitlab Inc. Class A 0.01% 658 $33K No change

Portfolio Sells Q1 2024 → Q2 2024

PATH Uipath Inc. Class A Reduce -49.9% 4.91% −7.69
SNOW Snowflake Inc. Reduce -49.8% 4.90% −3.50
DASH DoorDash Inc. Class A Reduce -19.1% 15.41% −1.96
CRWD CrowdStrike Holdings Inc. Class A Reduce -20.8% 0.03% +0.01
TOST Toast Inc. Class A Reduce -16.9% 0.04% +0.01
CADL Candel Therapeutics Inc. Reduce -50.0% 0.84% +0.53
NU Nu Holdings Ltd./Cayman Isl-A Reduce -20.0% 31.64% +5.30

Portfolio Buys Q1 2024 → Q2 2024

KVYO Klaviyo Inc. Class A Add +0.0% 29.31% +7.71
ACRV Acrivon Therapeutics Inc. Add +28.4% 4.12% +1.27
IOT Samsara Inc. Class A Add +18.7% 0.05% +0.02

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 24$613.5MALMR, NU, KVYO, BBNX, SGP
Q1 2026 21$421.2MNU, KVYO, SGP, BBNX, IKT
Q4 2025 20$518.5MKVYO, NU, BBNX, IKT, DASH
Q3 2025 20$456.4MNU, KVYO, BBNX, CPNG, DASH
Q2 2025 19$507.8MKVYO, NU, DASH, BBNX, CPNG
Q1 2025 20$408.9MKVYO, NU, DASH, BBNX, IKT
Q4 2024 21$459.7MKVYO, NU, DASH, IKT, CPNG
Q3 2024 20$355.8MKVYO, NU, DASH, BIOA, ACRV
Q2 2024 20$298.6MNU, KVYO, DASH, PATH, SNOW
Q1 2024 20$414.7MNU, KVYO, DASH, PATH, SNOW